CAMP
CAMP
NASDAQ · Biotechnology

Camp4 Therapeutics Corp

$4.31
-0.25 (-5.48%)
As of Mar 29, 10:35 PM ET ·
Financial Highlights (FY 2025)
Revenue
368.79M
Net Income
5.96M
Gross Margin
51.1%
Profit Margin
1.6%
Rev Growth
+17.9%
D/E Ratio
0.83
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 51.1% 51.1% 51.1%
Operating Margin 1.4% 1.6% 1.7%
Profit Margin 1.6% 1.3% 1.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 368.79M 346.38M 334.67M
Gross Profit 188.55M 177.10M 171.11M
Operating Income 5.18M 5.41M 5.54M
Net Income 5.96M 4.54M 4.70M
Gross Margin 51.1% 51.1% 51.1%
Operating Margin 1.4% 1.6% 1.7%
Profit Margin 1.6% 1.3% 1.4%
Rev Growth +17.9% -7.3% +7.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 81.61M 80.11M 79.74M
Total Equity 97.96M 93.68M 102.65M
D/E Ratio 0.83 0.86 0.78
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 7.81M 7.32M 6.13M
Free Cash Flow 4.41M 4.25M 6.96M